Intrinsic disorder in cell-signaling and cancer-associated proteins

Journal of Molecular Biology

Volumn 323, Issue 3, 2002, Pages 573-584

  Iakoucheva, Lilia M ^a   Brown, Celeste J ^a   Lawson, J David ^a   Obradović, Zoran ^b   Dunker, A Keith ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Cancer; Cell signaling; Intrinsic disorder; Protein folding; Unstructured protein

Indexed keywords

CYTOSKELETON PROTEIN; EUKARYOTIC PROTEIN; G PROTEIN COUPLED RECEPTOR; HUMAN CANCER ASSOCIATED PROTEIN; MEMBRANE PROTEIN; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN INHIBITOR; REGULATOR PROTEIN; SIGNALING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CANCER; DEGRADATION; DISEASE ASSOCIATION; METABOLISM; NERVE CELL NETWORK; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SWISS-PROT;

EUKARYOTA;

EID: 0036408751     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00969-5     Document Type: Article

References (63)

1. Wright, P. E. & Dyson, H. J. (1999). Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331.
2. Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S. et al. (2001). Intrinsically disordered protein. J. Mol. Graph. Model. 19, 26-59.
3. Uversky, V. N. (2002). What does it mean to be natively unfolded? Eur. J. Biochem. 269, 2-12.
4. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M. & Obradović, Z. (2002). Intrinsic disorder and protein function. Biochemistry, 41, 6573-6582.
5. Spolar, R. S. & Record, M. T., II (1994). Coupling of local folding to site-specific binding of proteins to DNA. Science, 263, 777-784.
6. Demchenko, A. P. (2001). Recognition between flexible protein molecules: Induced and assisted folding. J. Mol. Recogn. 14, 42-61.
7. Dyson, H. J. & Wright, P. E. (2002). Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12, 54-60.
8. Schulz, G. E. (1979). Nucleotide binding proteins. In Molecular Mechanism of Biological Recognition (Balaban, M., ed.), pp. 79-94, Elsevier/North-Holland, New York.
9. Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl Acad. Sci. USA, 93, 11504-11509.
10. Dunker, A. K. & Obradović, Z. (2001). The protein trinity-linking function and disorder. Nature Biotechnol. 19, 805-806.
11. Chervitz, S. A., Aravind, L., Sherlock, G., Ball, C. A., Koonin, E. V., Dwight, S. S. et al. (1998). Comparison of the complete protein sets of worm and yeast: Orthology and divergence. Science, 282, 2022-2028.
12. Dunker, A. K., Obradović, Z., Romero, P., Garner, E. C. & Brown, C. J. (2000). Intrinsic protein disorder in complete genomes. Genome Inform. 11, 161-171.
13. Sigler, P. B. (1988). Transcriptional activation. Acid blobs and negative noodles. Nature, 333, 210-212.
14. Romero, P., Obradović, Z., Li, X., Garner, E. C., Brown, C. J. & Dunker, A. K. (2001). Sequence complexity of disordered protein. Proteins: Struct. Funct. Genet. 42, 38-48.
15. Hartwell, L. H. & Kastan, M. B. (1994). Cell cycle control and cancer. Science, 266, 1821-1828.
16. Fearon, E. R. & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
17. DiGiammarino, E. L., Filippov, I., Weber, J. D., Bothner, B. & Kriwacki, R. W. (2001). Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein. Biochemistry, 40, 2379-2386.
18. Campbell, K. M., Terrell, A. R., Laybourn, P. J. & Lumb, K. J. (2000). Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry, 39, 2708-2713.
19. Metz, R., Bannister, A. J., Sutherland, J. A., Hagemeier, C., O'Rourke, E. C., Cook, A. et al. (1994). c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein. Mol. Cell Biol. 14, 6021-6029.
20. Bannister, A. J. & Kouzarides, T. (1995). CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14, 4758-4762.
21. Zhang, Y., Feng, X. H. & Derynck, R. (1998). Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature, 394, 909-913.
22. Demarest, S. J., Martinez-Yamout, M., Chung, J., Chen, H., Xu, W., Dyson, H. J. et al. (2002). Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature, 415, 549-553.
23. Lupas, A., Van Dyke, M. & Stock, J. (1991). Predicting coiled coils from protein sequences. Science, 252, 1162-1164.
24. Namba, K. (2001). Roles of partly unfolded conformations in macromolecular self-assembly. Genes Cells, 6, 1-12.
25. Gundersen, G. G. & Cook, T. A. (1999). Microtubules and signal transduction. Curr. Opin. Cell Biol. 11, 81-94.
26. Sastry, S. K. & Burridge, K. (2000). Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics. Expt. Cell. Res. 261, 25-36.
27. Bauch, A., Alt, F. W., Crabtree, G. R. & Snapper, S. B. (2000). The cytoskeleton in lymphocyte signaling. Advan. Immunol. 75, 89-114.
28. Fox, J. E. (2001). Cytoskeletal proteins and platelet signaling. Thromb. Haemost. 86, 198-213.
29. Behrens, J. (1999). Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Metastasis Rev. 18, 15-30.
30. Ban, N., Nissen, P., Hansen, J., Capel, M., Moore, P. B. & Steitz, T. A. (1999). Placement of protein and RNA structures into a 5 Å-resolution map of the 50 S ribosomal subunit. Nature, 400, 841-847.
31. Ban, N., Nissen, P., Hansen, J., Moore, P. B. & Steitz, T. A. (2000). The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science, 289, 905-920.
32. Williams, R. J. P. (1979). The conformational properties of proteins in solution. Biol. Rev. Camb. Phil. Soc. 54, 389-437.
33. Uversky, V., Gillespie, J. & Fink, A. (2000). Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins: Struct. Funct. Genet. 41, 415-427.
34. Romero, P., Obradović, Z., Kissinger, C. R., Villafranca, J. E. & Dunker, A. K. (1997). Identifying disordered regions in proteins from amino acid sequences. IEEE Int. Conf. Neural Netw. 1, 90-95.
35. Romero, P., Obradović, Z., Kissinger, C. R., Villafranca, J. E., Guilliot, S., Garner, E. et al. (1998). Thousands of proteins likely to have long disordered regions. Pac. Symp. Biocomput. 3, 437-448.
36. Adkins, J. N. & Lumb, K. J. (2002). Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57(Kip2). Proteins: Struct. Funct. Genet. 46, 1-7.
37. Ayed, A., Mulder, F. A., Yi, G. S., Lu, Y., Kay, L. E. & Arrowsmith, C. H. (2001). Latent and active p53 are identical in conformation. Nature Struct. Biol. 8, 756-760.
38. McEwan, I. J., Dahlman-Wright, K., Ford, J. & Wright, A. P. (1996). Functional interaction of the c-Myc transactivation domain with the TATA binding protein: Evidence for an induced fit model of transactivation domain folding. Biochemistry, 35, 9584-9593.
39. Bothner, B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J. & Kriwacki, R. W. (2001). Defining the molecular basis of Arf and Hdm2 interactions. J. Mol. Biol. 314, 263-277.
40. Lai, Z., Freedman, D. A., Levine, A. J. & McLendon, G. L. (1998). Metal and RNA binding properties of the hdm2 RING finger domain. Biochemistry, 37, 17005-17015.
41. Dunker, A. K., Brown, C. J. & Obradović, Z. (2002). Identification and functions of usefully disordered proteins. Advan. Protein Chem. 62, 25-49.
42. Garner, E., Romero, P., Dunker, A. K., Brown, C. & Obradović, Z. (1999). Predicting binding regions within disordered proteins. Genome Inform. 10, 41-50.
43. Xu, W., Doshi, A., Lei, M., Eck, M. J. & Harrison, S. C. (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell, 3, 629-638.
44. Ko, L. J. & Prives, C. (1996). p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072.
45. Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F. et al. (1999). Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev. 13, 1422-1437.
46. Nakayama, J., Rice, J. C., Strahl, B. D., Allis, C. D. & Grewal, S. I. (2001). Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science, 292, 110-113.
47. Ojala, P. M., Yamamoto, K., Castanos-Velez, E., Biberfeld, P., Korsmeyer, S. J. & Makela, T. P. (2000). The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nature Cell. Biol. 2, 819-825.
48. Wagner, A. (2001). The yeast protein interaction network evolves rapidly and contains few redundant duplicate genes. Mol. Biol. Evol. 18, 1283-1292.
49. Brown, C. J., Takayama, S., Campen, A. M., Vise, P., Marshall, T., Oldfield, C. J. et al. (2002). Evolutionary rate heterogeneity in proteins with long disordered regions. J. Mol. Evol. 55, 104-110.
50. Salghetti, S. E., Kim, S. Y. & Tansey, W. P. (1999). Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726.
51. Bajorath, J. (2001). Rational drug discovery revisited: Interfacing experimental programs with bio- and chemo-informatics. Drug Discov. Today, 6, 989-995.
52. Blundell, T. L. (1996). Structure-based drug design. Nature, 384, 23-26.
53. Traxler, P., Bold, G., Buchdunger, E., Caravatti, G., Furet, P., Manley, P. et al. (2001). Tyrosine kinase inhibitors: From rational design to clinical trials. Med. Res. Rev. 21, 499-512.
54. Bailey, R. W., Dunker, A. K., Brown, C. J., Garner, E. C. & Griswold, M. D. (2001). Clusterin: A binding protein with a molten globule-like region. Biochemistry, 40, 11828-11840.
55. Iakoucheva, L. M., Kimzey, A. L., Masselon, C. D., Bruce, J. E., Garner, E. C., Brown, C. J. et al. (2001). Identification of intrinsic order and disorder in the DNA repair protein XPA. Protein Sci. 10, 560-571.
56. Kingston, D. G. (1994). Taxol: The chemistry and structure-activity relationships of a novel anticancer agent. Trends Biotechnol. 12, 222-227.
57. de Pereda, J. M. & Andreu, J. M. (1996). Mapping surface sequences of the tubulin dimer and taxol-induced microtubules with limited proteolysis. Biochemistry, 35, 14184-14202.
58. Fang, G., Chang, B. S., Kim, C. N., Perkins, C., Thompson, C. B. & Bhalla, K. N. (1998). "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res. 58, 3202-3208.
59. Rodi, D. J., Janes, R. W., Sanganee, H. J., Holton, R. A., Wallace, B. A. & Makowski, L. (1999). Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J. Mol. Biol. 285, 197-203.
60. Haldar, S., Jena, N. & Croce, C. M. (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA, 92, 4507-4511.
61. Blagosklonny, M. V. (2001). Unwinding the loop of Bcl-2 phosphorylation. Leukemia, 15, 869-874.
62. Efron, B. & Tibshirani, R. (1993). An Introduction to the Bootstrap, Chapman & Hall, New York.
63. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. et al. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucl. Acids Res. 25, 3389-3402.